InvestorsHub Logo

fluteman

02/12/21 5:25 PM

#35730 RE: GD #35729

Maybe Geert tossed him some shares.
Lol

Biobonic

02/12/21 10:05 PM

#35737 RE: GD #35729

That's right GD, everyone that is cancer free and was in the Multikine arm knows it. How many have kept it a secret?

The method of administering Multikine necessitated that the trial be open label.

open-label study A clinical study in which the patients/subjects and investigators know which product each patient/subject is receiving, which is the opposite of a blinded study.



(Oh, here he goes with his quotes and url links again!)(I'll spare the links.)

? Multikine is administered in supra-physiological doses locally (near or close) to the tumor and the adjacent lymph nodes. 5days/wk for 3wks prior to surgery.

By a hypodermic needle

SOC only comparative arm - was not given a placebo shot 5days/wk for 3wks prior to surgery.

Participants and investigators know who received Multikine.

That is how it is open label study.

Like most people, am working diligently to de-risk this investment.

In one of my web fishing expeditions, found the telltale signs of others fishing for trial participants. Didn't get any bites...